What does Henogen do?
HENOGEN specializes in the development and production of advanced vaccine solutions. The company focuses on innovative technologies to enhance vaccine efficacy and safety. With a commitment to improving public health, HENOGEN aims to address global vaccination needs.
- Signals
-
Negative equityNegative equity € -4.55M
Equity is negative: debts exceed assets (technically insolvent).
Reporting lossesReporting losses € -14.91MThe company reported a loss in the latest financial year.
Poor liquidityPoor liquidity 0.49The current ratio is below 1: may be insufficient to cover short-term debt.
Negative cashflowNegative cashflow € -6.57MOperating cash flow was negative in the latest financial year.
Negative EBITDANegative EBITDA € -6.54MEBITDA is negative: operating activities are loss-making.
High turnoverHigh turnover € 48.74MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 18.0%Social debts stay manageable relative to personnel costs.
- Investments
- Ginkgo Parc 100%, Eebic
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
48.74M
|
€
58.60M
|
€
57.45M
|
€
71.45M
|
|
|
€
-6.54M
|
€
-1.55M
|
€
-3.30M
|
€
3.31M
|
|
|
€
-14.91M
|
€
-14.17M
|
€
-14.42M
|
€
-11.44M
|
|
|
€
-4.55M
|
€
10.56M
|
€
24.95M
|
€
39.67M
|
|
|
-4.68%
|
11.85%
|
28.26%
|
33.64%
|
|
|
€
98.16M
|
€
77.20M
|
€
61.98M
|
€
77.14M
|
|
|
€
1.05M
|
€
7.45M
|
€
44K
|
€
99K
|
|
|
206.20
|
293.60
|
294.90
|
319.50
|
Publications 68
All publications- Demissions, Nominations 02/04/2024
- Demissions, Nominations 23/06/2023
- Demissions, Nominations 16/01/2023
- Statuts (Traduction, Coordination, Autres Modifications, ) - Modification Forme Juridique - Demissions, Nominations 28/11/2022
- Demissions, Nominations 22/08/2022
Frequently asked questions
Answers to the most common questions about Henogen, based on official government data and the filed annual accounts.
What is the VAT number of Henogen?
The VAT number of Henogen is BE0467.455.074.
What is the official website of Henogen?
The official website of Henogen is Thermofisher.com.
How many employees work at Henogen?
In 2025, Henogen employed 206.20 full-time equivalents (FTE).
When was Henogen established?
Henogen was founded in 19-11-1999.
What is the official address of Henogen?
The official address of Henogen is Rue Des Prof Jeneer Et Brachet 12 Charleroi 6041.
What is the legal form of Henogen?
The juridical form of Henogen is Private limited company (BV/SRL).
What is the annual revenue of Henogen?
The revenue of Henogen for the 2025 financial year was €48,742,365.
What does Henogen do?
HENOGEN specializes in the development and production of advanced vaccine solutions. The company focuses on innovative technologies to enhance vaccine efficacy and safety. With a commitment to improving public health, HENOGEN aims to address global vaccination needs.
Is Henogen a reliable company?
Henogen is a registered Rechtspersoon with company number 0467.455.074 and can be verified through the official CBE database.
What is the credit limit of Henogen?
The estimated credit limit of Henogen is €1,463,896.
Is Henogen still active?
Henogen currently has the status "Normal situation" and is active.